Aehr remains a concentrated, expensive way to own wafer-level photonics burn-in: its 10-K says silicon-photonics customers primarily drove that revenue growth, and FY2027 guidance of $130m-$150m could nearly triple FY2026 sales, yet shares value it at about 20x the guide. Teradyne's acquired photonic-chip test business is not material to its much larger sales; Aehr's top five customers provided 70% of FY2026 revenue, so orders matter more than the headline CPO opportunity. x.com 

Aehr Test Systems is a case of narrative running ahead of the numbers. The bull case is reasonable: a young company with a strong position in silicon carbide burn-in, genuine hyperscaler interest in AI chip burn-in and room to expand into memory and logic. But the latest quarter showed revenue down 43% year over year, with no meaningful order conversion from the AI opportunities yet. Until revenue improves and orders come through more clearly, the story stays ahead of the fundamentals. x.com 

Aehr Test Systems' deals will get bigger and more frequent. Aehr received a record $41M follow-on order from its lead hyperscale customer for package-level burn-in of custom AI ASICs, bringing second-half bookings above $92M, and the stock jumped about 18%. Tens or hundreds of billions of dollars of optical networking equipment, plus coming HBM and HBF, will be installed over the next decade, and landing HBM4 and HBF burn-in deals would bring hockey-stick optionality. x.com  x.com 

Aehr Test Systems is unattractive near $100, at 22.5x sales and 112x forward earnings, even though it will very likely go above $100. Other burn-in names such as AEM Holdings look better placed to play catch-up. x.com 

Trio-Tech's burn-in board orders keep accelerating because every AI GPU and CPU must pass burn-in testing before it ships. It announced another $2.6 million of orders for boards supporting a next-generation AI GPU platform, lifting this quarter's total above $5 million on top of $5.3 million in March. Last quarter's revenue rose 124% year over year, and a new 104,000 sq ft lease in Penang points to a multi-year ramp. Gross margins remain under pressure as it scales. x.com 

Aehr Test Systems' thesis strengthened with its best report ever, though the stock's risk/reward is now impaired. The most important disclosure was that its lead AI customer has eliminated system-level burn-in and moved production entirely to Aehr's wafer-level systems. FY27 guidance of $130-150M far exceeded the $85M consensus. x.com 

Aehr Test Systems is key to AI manufacturing and can even be a bottleneck, but at almost 20x revenue through 2028 at the current price, it is stratospherically priced. The risk is giant if something goes wrong for the company or for the AI ramp, and even a slowdown could be deadly at such high valuations. Tech moats are not the same as financial moats. x.com 

Aehr Test Systems' bull case looks overstated on a detailed financial model, summarized in a table for investors meeting CEO Gayn at the William Blair conference. x.com 

Aehr Test Systems stands to benefit because testing is a bottleneck to scaling AI chips. Testing demand is about to surge. Investors did not question its price-to-sales ratio at 120, despite the current P/S objection. x.com  x.com 

Trio-Tech's second order for the same next-gen AI GPU platform shows the customer's production ramp is real. A $2.6 million order follows $5.3 million in March, about $8 million for one program, and customers don't reorder if the first batch failed. Every AI GPU must be burned in under extreme heat, voltage and load before shipping, making its burn-in boards a quiet, mandatory chokepoint. The roughly $160 million micro-cap doubled nine-month revenue to $48 million and is expanding in Malaysia. … Show more